Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

B8F.L (B8F) Regulatory News

12
Date Source Headline
16th Feb 2016 1:58 pm RNS Private Placement
11th Feb 2016 3:30 pm RNS Phase III studies update
28th Jan 2016 10:28 am RNS Excellent results in Ameluz BCC clinical study
26th Jan 2016 9:49 am RNS FDA completes Ameluz NDA mid-cycle review
20th Jan 2016 7:00 am RNS Notice of Cancellation from Trading on AIM
7th Jan 2016 7:00 am RNS CE Marking Granted for IndoorLux® Collaboration
31st Dec 2015 11:57 am RNS Total Voting Rights
23rd Dec 2015 2:30 pm RNS FDA Grants Small Business Waiver of US$2.3m
10th Dec 2015 7:00 am RNS Issue of equity and total voting rights
7th Dec 2015 7:00 am RNS Marketing approval for Ameluz® in Switzerland
23rd Nov 2015 3:05 pm RNS Result of Open Offer and Private Placement
20th Nov 2015 7:00 am RNS 3rd Quarter Report
19th Nov 2015 8:00 am RNS Final patient visit in Phase III trial for BCC
12th Nov 2015 1:00 pm RNS Notice of Q3 Results
11th Nov 2015 12:00 pm RNS Business Operations on Track
5th Nov 2015 11:32 am RNS Further re: Subscription Price of New Shares
28th Oct 2015 3:23 pm RNS Further re: Open Offer and Private Placement
27th Oct 2015 11:31 am RNS Open Offer and Private Placement
2nd Oct 2015 7:00 am RNS FDA shortens review period for Ameluz
22nd Sep 2015 7:00 am RNS Excellent long term results of Phase III trial
14th Sep 2015 7:00 am RNS FDA accepts filing of Ameluz® and BF-RhodoLED®
1st Sep 2015 7:03 am RNS Result of AGM
14th Aug 2015 7:00 am RNS Half Year Results
7th Aug 2015 7:00 am RNS Notice of Results
22nd Jul 2015 7:00 am RNS Appointment of Chief Commercial Officer
20th Jul 2015 7:00 am RNS Belixos® Protect product launch
17th Jul 2015 7:00 am RNS Notice of AGM
13th Jul 2015 9:45 am RNS FDA New Drug Application submitted for Ameluz®
22nd Jun 2015 7:00 am RNS Final stage completed ahead of FDA submission
19th Jun 2015 6:10 pm RNS Issue of equity and total voting rights
29th May 2015 7:00 am RNS Strong Performance for Q1 2015
28th May 2015 7:00 am RNS Result of Open Offer & Private Placement
26th May 2015 7:01 am RNS Notice of First Quarter Results 2015
6th May 2015 7:02 am RNS Publication of PIII Study for Actinic Keratosis
27th Apr 2015 2:58 pm RNS Further re Open Offer and Private Placement
23rd Apr 2015 1:36 pm RNS Open Offer and Private Placement
20th Apr 2015 7:00 am RNS US subsidiary and CEO US Operations Appointed
17th Apr 2015 7:00 am RNS Q1 Preliminary Trading Update
10th Apr 2015 7:00 am RNS Final Results
8th Apr 2015 7:00 am RNS Off Market Block Trade Completed
12
FTSE 100 Latest
Value8,809.74
Change53.53